flurazepam has been researched along with Bruxism, Nocturnal in 1 studies
Flurazepam: A benzodiazepine derivative used mainly as a hypnotic.
flurazepam : A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a 2-(diethylamino)ethyl group, 2-fluorophenyl group and chloro group at positions 1, 5 and 7, respectively. It is a partial agonist of GABAA receptors and used for the treatment of insomnia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chisini, LA | 1 |
| San Martin, AS | 1 |
| Cademartori, MG | 1 |
| Boscato, N | 1 |
| Correa, MB | 1 |
| Goettems, ML | 1 |
1 review available for flurazepam and Bruxism, Nocturnal
| Article | Year |
|---|---|
Interventions to reduce bruxism in children and adolescents: a systematic scoping review and critical reflection.
Topics: Adolescent; Age Factors; Child; Female; Flurazepam; Humans; Male; Occlusal Splints; Patient Satisfac | 2020 |